Core Viewpoint - Meihao Medical's stock price has shown volatility, with a slight increase recently, but a decline over the past five trading days and year-to-date. The company operates in the medical device sector, focusing on the design, development, manufacturing, and sales of medical equipment components [1][2]. Financial Performance - For the first half of 2025, Meihao Medical reported a revenue of 733 million yuan, representing a year-on-year growth of 3.73%. However, the net profit attributable to shareholders decreased by 32.44% to 114 million yuan [2]. - Since its A-share listing, Meihao Medical has distributed a total of 248 million yuan in dividends [3]. Stock Market Activity - As of October 15, Meihao Medical's stock price was 22.99 yuan per share, with a market capitalization of 13.078 billion yuan. The stock has experienced a year-to-date decline of 0.49% and a significant drop of 8.19% over the last five trading days [1]. - The stock has been featured on the "Dragon and Tiger List" twice this year, with the most recent appearance on August 25 [1]. Shareholder Structure - As of September 19, the number of shareholders for Meihao Medical was 15,000, a decrease of 7.94% from the previous period. The average number of circulating shares per shareholder increased by 8.63% to 10,418 shares [2]. - The top shareholders include Huabao Zhongzheng Medical ETF and several new institutional investors, indicating a shift in the shareholder base [3].

Group 1 - The stock price of Meihao Medical (301363) closed at 23.28 yuan on October 13, 2025, down by 2.1% with a turnover rate of 3.54% and a trading volume of 55,200 shares, amounting to a transaction value of 128 million yuan [1][2] - On October 13, the net outflow of main funds was 15.3741 million yuan, while retail investors saw a net inflow of 17.8014 million yuan [2] Group 2 - Meihao Medical announced that 412,300,000 shares, accounting for 72.4769% of the total share capital, will be released from restrictions and listed for trading on October 16, 2025 [1][2] - The total share capital of the company is 568,871,180 shares, and the shareholders applying for the release of restrictions have complied with relevant commitments without any non-operational fund occupation or illegal guarantees [1]

Core Viewpoint - Meihua Medical (301363) announced the lifting of restrictions on shares issued prior to its initial public offering, allowing for the circulation of a significant portion of its total shares [1] Group 1 - The number of restricted shares being released is 412,300,000, which accounts for 72.4769% of the company's total share capital [1] - The number of shareholders involved in this release is five [1] - The lifting of restrictions will take effect on October 16, 2025, which is 36 months after the company's initial public offering [1]

证券代码：301363 证券简称：美好医疗 公告编号：2025-067 深圳市美好创亿医疗科技股份有限公司 关于首次公开发行前已发行股份上市流通的提示性公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 1、本次解除限售的股份为深圳市美好创亿医疗科技股份有限公司（以下简 称"公司"、"发行人"）首次公开发行前已发行的股份。本次解除限售股东户数 共计5户，解除限售股份数量为412,300,000股，占公司总股本的72.4769%，限售 期为自公司首次公开发行股票并上市之日起36个月。 2、本次解除限售股份的上市流通日期为2025年10月16日（星期四）。 一、公司首次公开发行和股本变动情况 根据中国证券监督管理委员会《关于同意深圳市美好创亿医疗科技股份有限 公司首次公开发行股票注册的批复》（证监许可〔2022〕1441号）和深圳证券交 易所《关于深圳市美好创亿医疗科技股份有限公司人民币普通股股票在创业板上 市的通知》（深证上〔2022〕986号），公司首次向社会公众公开发行人民币普 通股（A股）4,427万股，并于2022年10月12日在深圳证券交 ...

关于深圳市美好创亿医疗科技股份有限公司 首次公开发行前已发行股份解除限售并上市流通 的核查意见 东兴证券股份有限公司（以下简称"东兴证券"或"保荐机构"）作为深圳 市美好创亿医疗科技股份有限公司（以下简称"美好医疗"、"上市公司"或"公 司"）首次公开发行股票并在创业板上市的保荐机构，根据《证券发行上市保荐 业务管理办法（2025 年修订）》《深圳证券交易所创业板股票上市规则（2025 年 修订）》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范 运作（2025 修订）》等相关法律、法规和规范性文件的规定，对美好医疗首次公 开发行前已发行股份解除限售并上市流通事项进行了核查，具体情况如下： 一、公司首次公开发行和股本变动情况 根据中国证券监督管理委员会《关于同意深圳市美好创亿医疗科技股份有限 公司首次公开发行股票注册的批复》（证监许可〔2022〕1441 号）和深圳证券交 易所《关于深圳市美好创亿医疗科技股份有限公司人民币普通股股票在创业板上 市的通知》（深证上〔2022〕986 号），公司首次向社会公众公开发行人民币普通 股（A 股）4,427 万股，并于 2022 年 10 月 12 ...

Core Viewpoint - On October 10, Meihao Medical experienced a decline of 1.82% with a transaction volume of 111 million yuan, indicating a high level of trading activity and investor interest in the stock [1] Financing Summary - On October 10, Meihao Medical had a financing buy-in amount of 15.31 million yuan and a financing repayment of 11.07 million yuan, resulting in a net financing buy-in of 4.24 million yuan [1] - As of October 10, the total financing and securities lending balance for Meihao Medical was 194 million yuan, with the financing balance accounting for 5.20% of the circulating market value, which is above the 90th percentile level over the past year [1] - The company had no shares repaid in securities lending on October 10, with 1,300 shares sold short, amounting to 30,900 yuan at the closing price [1] - The securities lending balance was 986,400 yuan, also exceeding the 90th percentile level over the past year [1] Company Overview - Meihao Medical, established on July 15, 2010, and listed on October 12, 2022, is located in Longgang District, Shenzhen, Guangdong Province, specializing in the design, development, manufacturing, and sales of medical device components [2] - The main revenue sources for Meihao Medical include home respiratory machine components (59.48%), home and consumer electronics components (14.61%), other medical product components (10.33%), cochlear implant components (8.16%), precision molds and automation equipment (5.63%), and other categories (1.09%) [2] - For the first half of 2025, Meihao Medical reported a revenue of 733 million yuan, a year-on-year increase of 3.73%, while the net profit attributable to the parent company was 114 million yuan, a year-on-year decrease of 32.44% [2] Dividend and Shareholder Information - Since its A-share listing, Meihao Medical has distributed a total of 248 million yuan in dividends [3] - As of June 30, 2025, the top ten circulating shareholders included Huabao Zhongzheng Medical ETF (512170) as the second-largest shareholder with 5.694 million shares, an increase of 1.6179 million shares from the previous period [3] - New shareholders include Rongtong Health Industry Flexible Allocation Mixed A/B (000727) with 5 million shares, and several other funds have increased their holdings, while some have exited the top ten list [3]

本周内计划发布但同样可能延迟的数据包括：9月零售销售数据、9月生产者价格指数PPI（均于周四发 布），以及当周初请失业金人数；周五则将公布9月新屋开工数据与9月工业产出数据。 花旗分析师在报告中指出："受停摆影响，新数据供应稀缺，本月降息的可能性较大，且市场已完全消 化这一预期。"伦敦证券交易所集团（LSEG）数据显示，市场定价暗示美联储有望在10月29日的会议及 12月进一步降息。 编辑 | 格蕾丝 本周外盘看点 上周国际市场风云变幻，关税阴云再起，黄金再迎里程碑。美股全线下挫，道指周跌2.73%，纳指周跌 2.53%，标普500指数周跌2.43%。欧洲三大股指表现不佳，英国富时100指数周跌0.67%，德国DAX 30 指数周跌0.56%，法国CAC 40指数周跌2.02%。 本周看点颇多，市场持续关注美国政府停摆的相关进展以及美联储是否会释放进一步降息的信号。若停 摆持续，更多经济数据可能会延迟发布，此外多位美联储官员将发表例行讲话。在欧洲，通胀数据将影 响未来政策路径走向，英国与澳大利亚将公布关键就业数据。世界银行和国际货币基金组织（IMF）的 秋季年会召开，届时将公布最新经济展望。美股新财报季拉开帷 ...

智通财经APP获悉，10月13日共有29家上市公司的限售股解禁，解禁总市值约445.53亿元。 | 股票简称 | 股票代码 | 限售股类型 | 解禁股数 | | --- | --- | --- | --- | | 招商港口 | 001872 | 增发A股法人配售上市 | 5.77亿 | | 丰原药业 | 000153 | 股权激励限售流通 | 596.55万 | | 中色股份 | 000758 | 股权激励限售流通 | 7.43万 | | 东方钽业 | 000962 | 股权激励限售流通 | 3.96万 | | 爱旭股份 | 600732 | 股权激励限售流通 | 102.06万 | | 陕鼓动力 | 601369 | 股权激励限售流通 | 1652.67万 | | 宝鼎科技 | 002552 | 增发A股法人配售上市 | 1992.66万 | | 高能环境 | 603588 | 股权激励限售流通 | 296万 | | 九强生物 | 300406 | 股权激励限售流通 | 190.58万 | | 快可电子 | 301278 | 股权激励限售流通 | 3.68万 | | 伊戈尔 | 002922 | 股权激励限 ...

Macro Economy - The Chinese Ministry of Commerce expressed strong opposition to the U.S. announcement of imposing a 100% tariff on Chinese goods, stating that it severely harms China's interests and disrupts the atmosphere for bilateral economic talks. China maintains a consistent stance of not wanting to engage in trade conflicts but is not afraid to do so if necessary [5] - The State Post Bureau reported that as of October 11, the express delivery volume in China has exceeded 1.5 billion packages this year, reaching this milestone 37 days earlier than in 2024 [5] Investment News - Bitcoin surged above $115,000, increasing by 4.25% in the past 24 hours, while Ethereum rose over 11% to above $4,100, currently priced at $4,147.5 [7] - A total of 58 restricted shares will be unlocked this week, amounting to 3.603 billion shares with a market value of 84.144 billion yuan. Among these, China Merchants Port leads with 11.967 billion yuan in unlocked shares [7] - As of October 12, 51 A-share companies have disclosed their third-quarter earnings forecasts, with 42 companies expecting positive results, resulting in a positive forecast ratio of 82.35% [8] - Since September, brokerage firms have conducted research on over 880 listed companies, with the highest numbers in the machinery, electronics, and pharmaceutical sectors [8] Company Movements - Wentai Technology announced that its control over Anshi is temporarily restricted, with trading resuming on October 13. The company condemned attempts by certain foreign management to alter the ownership structure through legal means, which are linked to political pressure [10] - Microsoft will cease providing security updates and technical support for Windows 10 starting October 14, which may expose many users' computers to increased cybersecurity risks [10]

// 市场要闻 // 1 、 10 月 15 日，国家统计局将公布 9 月 CPI 、 PPI 数据。除 CPI 、 PPI 外， 9 月新增 贷款、 M2 、社融等金融数据也即将公布。 2 、根据"十个工作日"原则，本轮调价窗口为 10 月 13 日 24 时。据金联创测算，截至 10 月 10 日第八个工作日，参考原油品种均价为 64.97 美元 / 桶，变化率为 -0.34% ，对应 的国内汽柴油零售价应下调 20 元 / 吨。 3 、由工业和信息化部、交通运输部、北京市人民政府共同主办的 2025 世界智能网联汽车 大会将于 10 月 16 日 -10 月 18 日在北京举办。大会将聚焦人工智能、信息通信、数据利 用、芯片等前沿科技在内的汽车产业应用创新，与全球多国海外政府机构相关负责人、专家 分享中国智能网联汽车产业领域的最新技术突破、产业趋势。 4 、北京时间周六早上 5 时 20 分左右开始， USDe 在某知名交易所的现货价格突然脱锚， 在之后的半个小时里最低跌至 0.65 美元。整场风波持续了近两个小时，期间多种主流货币的 封装代币同步暴跌，共同形成币圈历史级别的大爆仓。 在 CoinMar ...